BTSG — Brightspring Health Services Income Statement
0.000.00%
- $8.29bn
- $10.74bn
- $12.91bn
Annual income statement for Brightspring Health Services, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6,698 | 7,721 | 7,691 | 10,072 | 12,911 |
| Cost of Revenue | |||||
| Gross Profit | 1,248 | 1,354 | 1,139 | 1,266 | 1,518 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 6,464 | 7,533 | 7,633 | 9,977 | 12,615 |
| Operating Profit | 234 | 188 | 58.1 | 95.2 | 295 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 68.9 | -45.8 | -214 | -95.3 | 138 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 51.3 | -54.2 | -182 | -68.9 | 105 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 49.8 | -53.9 | -155 | -18.1 | 191 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 49.8 | -53.9 | -155 | -18.1 | 191 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.496 | 0.136 | -1.53 | 0.088 | 0.83 |